Skip to content
Update Central 360

The Zimbabwean Government Turns Down ‘Unbalanced’ American Healthcare Assistance Deal Due to Data Concerns

Medical funding illustration
The proposed American financial assistance would have supported programmes for HIV/Aids treatment and prevention, tuberculosis, and malaria.

Zimbabwe has declined a substantial US healthcare agreement valued at 367 million US dollars (£272m) spanning five years due to Washington's demand for confidential information.

This move was revealed after a government memo dated December was leaked, indicating that President Emmerson Mnangagwa felt the agreement was "lopsided".

An official spokesman later clarified that the US was demanding access to biological samples for research and profit but refused to guarantee the resulting advantages from future vaccines.

"We will now turn to the difficult and regrettable task of ending our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the United States had donated over $1.9bn as health assistance to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has urged further talks to secure a agreement suitable to all parties so the country's vital HIV treatment initiative can be sustained.

Broader Implications

This development comes after a similar case in neighbouring Kenya, where a high court blocked a related deal with the US after concerns were filed about the safety of citizens' medical information.

After resuming the presidency recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).

The agency had administered assistance for the American government, but Trump claimed its spending was "wasteful" and his administration was pursuing government-to-government deals to enhance transparency and accountability.

According to statements, 16 African countries have so far agreed to similar health pacts, constituting more than $18.3bn of fresh investment.

Details of the Declined Deal

The money for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this collaboration might have yielded significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently on HIV treatment through US-supported programmes," Tremont said.

However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".

"The proposal required Zimbabwe to share its biological resources and data over an extended period, without any equivalent guarantee of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might result from that provided information," he stated.

"In essence, our country would provide the basic resources for scientific discovery with no assurance that the resulting innovations would be accessible to our people if a future health crisis emerge."

National Interest and International Frameworks

Mangwana further noted that the American exit from the global health body and its pursuit of one-on-one deals were upending structures previously established via the international health agency.

The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to deal with future global health emergencies.

"This system is intended to ensure that when a nation contributes its samples, the benefits – such as medicines and cures – are shared equitably, not commercialised solely by those with the funds to develop them."

These objections over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We welcome continued dialogue with our American counterparts on how subsequent collaboration might be structured in a way that respects the sovereignty and dignity of each country."

Health Experts Response

Medical experts expressed it acknowledged the government's concerns, but suggested that talks should continue considering a large portion of the country's HIV programmes were funded by external financing.

"Where technical issues arise, including those involving data governance or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," the group said.

The situation emphasises the ongoing debate between receiving much-needed international aid and safeguarding a country's data in an increasingly interconnected world.

About the author

Justin Garcia

Tech journalist with over a decade of experience covering emerging technologies and digital innovation trends across Europe.

Update Central 360

Type to search articles.